AQP4 and neuromyelitis optica: Although favorable responses to those treatments have been reported, they are often incomplete.45 Recognition that AQP4-specific antibodies are T cell-dependent, and alone are not pathogenic in the absence of CNS inflammation, suggests that therapies directed against the cellular arm of NMO pathogenesis could be beneficial.